Results 91 to 100 of about 952 (167)

First detection and molecular characterization of rabbit hemorrhagic disease virus (RHDV) in Algeria

open access: yesFrontiers in Veterinary Science, 2023
Since the first detection of rabbit hemorrhagic disease (RHD), the rabbit hemorrhagic disease virus (RHDV) has been responsible for high morbidity and mortality worldwide, both in domestic and in wild rabbits.
Lynda Sahraoui   +13 more
doaj   +1 more source

Validation of plasmonic-based biosensors for rapid and in depth characterization of monoclonal antibodies directed against rabbit haemorrhagic and foot-and-mouth disease viruses in biological samples [PDF]

open access: yes
: ELISA and RT-PCR represent the standard tools for the sensitive identification of viruses in biological samples, but they lack the capacity to finely characterize the binding of viruses or viral antigens to monoclonal antibodies (MAbs).
Capucci, Lorenzo   +5 more
core   +1 more source

Co‐infection by classic MYXV and ha‐MYXV in Iberian hare (Lepus granatensis) and European wild rabbit (Oryctolagus cuniculus algirus) [PDF]

open access: yes, 2022
Research Areas: Infectious Diseases ; Veterinary SciencesMyxomatosis is an emergent disease in the Iberian hare (Lepus granatensis). In this species, the disease is caused by a natural recombinant virus (ha-myxoma virus [MYXV]) identified for the first ...
Abade Dos Santos, F.A.   +6 more
core   +1 more source

Worldwide rapid spread of the novel rabbit haemorrhagic disease virus (GI.2/RHDV2/b).

open access: yesTransboundary and Emerging Diseases, 2019
We describe the extremely rapid worldwide spread of the Lagovirus europaeus/GI.2/RHDV2/b (henceforth GI.2), the causative infectious agent of the so-called 'novel' rabbit haemorrhagic disease of the European rabbit (Oryctolagus cuniculus).
C. Rouco   +4 more
semanticscholar   +1 more source

Emerging RHDV2 suppresses the impact of endemic and novel strains of RHDV on wild rabbit populations

open access: yes, 2020
Multi-strain, host-disease dynamics describe a system where multiple strains of a pathogen compete for susceptible individuals of a single host. The theoretical properties of these systems have been well studied, but there are few empirical studies in ...
D. Ramsey   +7 more
semanticscholar   +1 more source

Novel Trivalent Vectored Vaccine for Control of Myxomatosis and Disease Caused by Classical and a New Genotype of Rabbit Haemorrhagic Disease Virus

open access: yesVaccines, 2020
Myxoma virus (MV) and rabbit haemorrhagic disease virus (RHDV) are the major causes of lethal viral diseases in the European rabbit. In 2010, a new RHDV genotype (RHDV2) emerged in the field that had limited cross-protection with the classical RHDV ...
Sylvia Reemers   +6 more
doaj   +1 more source

Detection of a new emerging strain of rabbit haemorrhagic disease virus 2 (GI.2) in China

open access: yesJournal of Veterinary Research, 2022
In May 2020, an outbreak of rabbit haemorrhagic disease 2 (RHD2) caused by the rabbit haemorrhagic disease virus 2 (RHDV2, GI.2) occurred in Sichuan, China.
Chen Wanting   +6 more
doaj   +1 more source

Factors predisposing rabbits to rabbit hemorrhagic disease (RHD) in Oyo State, Nigeria [PDF]

open access: yes, 2022
Rabbit Hemorrhagic Disease (RHD) is a highly infectious fatal viral disease of economic importance which was implicated in recent outbreak among rabbits in South-West Nigeria.
Akintayo, O.I.   +2 more
core   +1 more source

Study on novel vaccines and adjuvants for rabbit infectious diseases [PDF]

open access: yes
Epidemic diseases have seriously damaged the development of the global rabbit industry. Vaccination plays a vital role in improving the health and welfare of livestock and preventing animal-tohuman transmission, thereby constituting a major public health
Bao, Guolian   +5 more
core   +2 more sources

Optimization of RHDV type 1 and 2 inactivation modes

open access: yesВетеринария сегодня, 2021
The purpose of these studies was to optimize RHDV type 1 and 2 (RHDV1 and RHDV2) inactivation modes to use the obtained antigens in inactivated vaccines and diagnosticums.
E. D. Kunikova   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy